| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.17▲ | 12.21▼ | 12.21▼ | 12.17▼ | 11.72▲ |
| MA10 | 12.19▼ | 12.16▲ | 12.14▲ | 12.05▲ | 10.66▲ |
| MA20 | 12.14▲ | 12.14▲ | 12.15▲ | 11.69▲ | 10.13▲ |
| MA50 | 12.14▲ | 12.33▼ | 12.22▼ | 10.56▲ | 11.87▲ |
| MA100 | 12.28▼ | 12.12▲ | 11.83▲ | 10.13▲ | 12.32▼ |
| MA200 | 12.19▼ | 11.72▲ | 11.07▲ | 11.43▲ | 13.57▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.018▲ | 0.005▲ | -0.014▼ | 0.420▲ |
| RSI | 50.044▲ | 49.235▼ | 49.410▼ | 58.309▲ | 58.980▲ |
| STOCH | 41.524 | 64.673 | 40.733 | 63.177 | 76.853 |
| WILL %R | -47.059 | -57.500 | -60.989 | -32.723 | -16.863▲ |
| CCI | -20.741 | 22.577 | 23.963 | 52.776 | 126.105▲ |
|
Saturday, August 16, 2025 07:31 AM
Key Insights Significant insider control over Greenwich LifeSciences implies vested interests in company growth The ...
|
|
Wednesday, August 13, 2025 03:18 AM
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
|
|
Monday, August 11, 2025 03:05 AM
The following videos, which include CEO interviews, are now available on the Company’s website at the bottom of the Welcome page: https://greenwichlifesciences.com/ The Company's recent prior events ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 12.20 | 12.29 | 11.96 | 12.17 | 19,800 |
| 14/08/25 | 11.70 | 12.60 | 11.70 | 12.08 | 98,855 |
| 13/08/25 | 12.50 | 12.696 | 11.78 | 11.78 | 51,600 |
| 12/08/25 | 12.61 | 12.83 | 12.33 | 12.35 | 67,789 |
| 11/08/25 | 12.34 | 12.698 | 12.22 | 12.49 | 41,427 |
| 08/08/25 | 11.81 | 12.885 | 11.81 | 12.18 | 92,300 |
| 07/08/25 | 12.23 | 12.30 | 11.4675 | 11.67 | 79,684 |
| 06/08/25 | 11.73 | 12.208 | 11.51 | 12.10 | 26,301 |
| 05/08/25 | 12.00 | 12.00 | 11.57 | 11.72 | 17,100 |
| 04/08/25 | 11.20 | 11.94 | 11.10 | 11.94 | 38,500 |
|
|
||||
|
|
||||
|
|